• Sign In
  • Register
  • Glossary
  • Share/Bookmark
  • RSS

Expert Opinions

CSL Behring & Therapies

Coagulation therapy is the foundation of CSL Behring’s broad range of therapies.

Learn More

Research Efforts

CSL Behring is committed to the future research and development of coagulation therapies.

Learn More

All About Bleeding Disorders

Get the facts about bleeding disorders, including VWD and hemophilia.

Learn More


The CSL Behring Key Issues Dialogue Series

CSL Behring sponsors candid discussions with key thought leaders and CSL Behring executives on issues important to the patient communities we serve. These dialogues provide unique perspectives on the trends, issues, challenges and opportunities seen by these leaders.

Recent editions of the Key Issues Dialogue Series include:

Rare Diseases
In conjunction with Rare Disease Day 2011, CSL Behring has published a special edition in its Key Issues Dialogue Series — "Making Rare Diseases a Global Public Health Priority." The Dialogue brought together thought leaders in Europe and the US to address the challenges to making rare diseases a global health priority.
Download a printable PDF version

Hemophilia
Leaders of European hemophilia societies joined representatives of CSL Behring in Marburg, Germany for a discussion of the state of hemophilia care.
Download a printable PDF version

Quality and Safety
This dialogue explains the many quality and safety processes and procedures employed by CSL Behring to ensure the production of safe and effective biotherapies.
Download a printable PDF version

Standards of Care Legislation
Leaders from patient communities in the United States met to talk about standards of care surrounding rare diseases such as bleeding disorders and immune deficiencies.
Download a printable PDF version

ITP
Leaders from the ITP community met to talk about diagnosis, treatment, developments and challenges surrounding ITP.
Download a printable PDF version

von Willebrand Disease
Three well-known members of the bleeding disorders community met to discuss challenges and advances in diagnosis and treatment of von Willebrand disease.
Download a printable PDF version


Last Updated: 2/25/2011 4:28 PM
  • E-mail
  • Print
  • Share